GoHealth, Inc. (NASDAQ:GOCO) Sees Large Decline in Short Interest

GoHealth, Inc. (NASDAQ:GOCO) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 129,400 shares, a drop of 8.7% from the December 31st total of 141,700 shares. Based on an average trading volume of 38,900 shares, the short-interest ratio is currently 3.3 days. Approximately 1.6% of the company’s shares are sold short.

Hedge Funds Weigh In On GoHealth

A number of institutional investors have recently added to or reduced their stakes in GOCO. JPMorgan Chase & Co. grew its stake in GoHealth by 99.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company’s stock valued at $79,000 after purchasing an additional 4,204 shares in the last quarter. Barclays PLC boosted its stake in shares of GoHealth by 83.9% during the 3rd quarter. Barclays PLC now owns 9,580 shares of the company’s stock valued at $89,000 after buying an additional 4,372 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of GoHealth by 22.0% during the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock worth $178,000 after buying an additional 3,300 shares in the last quarter. Empowered Funds LLC increased its stake in shares of GoHealth by 5.1% in the third quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock worth $207,000 after buying an additional 1,072 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in GoHealth by 3.2% in the third quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock valued at $973,000 after acquiring an additional 3,205 shares in the last quarter. Institutional investors and hedge funds own 24.21% of the company’s stock.

GoHealth Stock Up 0.5 %

Shares of NASDAQ:GOCO traded up $0.08 during midday trading on Friday, hitting $16.30. 18,205 shares of the company’s stock traded hands, compared to its average volume of 62,262. The firm’s fifty day moving average price is $13.43 and its two-hundred day moving average price is $11.45. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. GoHealth has a twelve month low of $7.27 and a twelve month high of $18.20. The company has a market cap of $373.43 million, a PE ratio of -4.66 and a beta of 1.64.

GoHealth (NASDAQ:GOCO) last issued its earnings results on Thursday, November 7th. The company reported ($3.73) earnings per share for the quarter, missing the consensus estimate of ($3.19) by ($0.54). The company had revenue of $118.29 million during the quarter, compared to analysts’ expectations of $105.93 million. GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. During the same period in the previous year, the company earned ($2.61) EPS. On average, equities research analysts anticipate that GoHealth will post -5.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $13.00 target price on shares of GoHealth in a research report on Monday, October 21st.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.